Sternke-Hoffmann, R.; Peduzzo, A.; Bolakhrif, N.; Haas, R.; Buell, A.K.
The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation. Int. J. Mol. Sci. 2020, 21, 1995.
https://doi.org/10.3390/ijms21061995
AMA Style
Sternke-Hoffmann R, Peduzzo A, Bolakhrif N, Haas R, Buell AK.
The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation. International Journal of Molecular Sciences. 2020; 21(6):1995.
https://doi.org/10.3390/ijms21061995
Chicago/Turabian Style
Sternke-Hoffmann, Rebecca, Alessia Peduzzo, Najoua Bolakhrif, Rainer Haas, and Alexander K. Buell.
2020. "The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation" International Journal of Molecular Sciences 21, no. 6: 1995.
https://doi.org/10.3390/ijms21061995
APA Style
Sternke-Hoffmann, R., Peduzzo, A., Bolakhrif, N., Haas, R., & Buell, A. K.
(2020). The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation. International Journal of Molecular Sciences, 21(6), 1995.
https://doi.org/10.3390/ijms21061995